First-pass extracted concept

Efficacy, Safety, and Accessibility (ESA) framework

Candidate: concept label1 source documents4 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

ESA framework

Extracted Explainers

What the tool is doing

The ESA framework is presented as a comprehensive design framework for engineering next-generation Smart CAR-T cells. It organizes strategies around efficacy, safety, and accessibility.

Source 1DOI PubMed

What problem it solves

It addresses the need to jointly consider tumor killing, toxicity control, and broader deployability in CAR-T engineering.

Source 1DOI PubMed

Evidence Snippets

this review proposes a comprehensive Efficacy, Safety, and Accessibility (ESA) framework for engineering next-generation "Smart" CAR-T cells

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1framework proposalsupports2026Source 1DOI PubMed

The review proposes an Efficacy, Safety, and Accessibility framework for engineering next-generation Smart CAR-T cells.

Claim 2problem statementsupports2026Source 1DOI PubMed

CAR-T therapy has achieved major success in hematological malignancies but faces major challenges in solid tumors.

Claim 3problem statementsupports2026Source 1DOI PubMed

Key solid-tumor limitations for CAR-T include on-target off-tumor toxicity, antigen heterogeneity, and an immunosuppressive tumor microenvironment with extracellular-matrix barriers to T-cell infiltration.

Claim 4vision statementsupports2026Source 1DOI PubMed

Integrating logic gates, conditional activation, allogeneic strategies, and AI/ML is presented as a new precision-immunotherapy paradigm for making CAR-T cells intelligent, controllable, and more accessible against complex solid tumors.